Journal article icon

Journal article

A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.

Abstract:

We conducted a cost-effectiveness analysis of genetic testing for smoking cessation, based on data available from the published pharmacogenetic studies of nicotine replacement therapy and bupropion, and a previous cost-effectiveness analysis of smoking cessation treatments. We use multiparameter evidence synthesis methods to combine evidence on cessation by genotype with evidence on cessation irrespective of genotype (which can be written as a function of genotype-specific parameters). Our in...

Expand abstract

Actions


Access Document


Publisher copy:
10.1080/14622200701767761

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Oncology
Role:
Author
Journal:
Nicotine and tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Volume:
10
Issue:
1
Pages:
231-240
Publication date:
2008-01-05
DOI:
EISSN:
1469-994X
ISSN:
1462-2203
URN:
uuid:901a8290-c4a0-452f-ad7c-20f5695081d7
Source identifiers:
289480
Local pid:
pubs:289480

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP